Seeking Alpha
26 Oct 2026, 11:50 UTC · 1h ago
Abbott Laboratories: A New Growth Story Takes Shape
Impact · against what's priced in
The news is largely neutral for ABT as the market has already priced in the current growth targets and the operational benefits of the Exact Sciences acquisition. The projected margin expansion from the Nutrition spin-off provides a slight catalyst as it addresses free cash flow expansion the market currently declines to value.
- ABT+0.15
Challenges what's priced in
- The price assumes
A significant expansion in free cash flow margin beyond the current 16.7%
The market is currently not paying for free cash flow margin expansion, but the planned Nutrition spin-off is expected to increase gross margins by 200 bps and operating margins by 100 bps.
What ABT's price assumes · Sep 12
